An Error Occurred: Forbidden

Oops! An Error Occurred

The server returned a "403 Forbidden".

Something is broken. Please let us know what you were doing when this error occurred. We will fix it as soon as possible. Sorry for any inconvenience caused.
An Error Occurred: Forbidden

Oops! An Error Occurred

The server returned a "403 Forbidden".

Something is broken. Please let us know what you were doing when this error occurred. We will fix it as soon as possible. Sorry for any inconvenience caused.
Børs og finans

Varsler emisjon i Biotec Pharmacon

Mye spennende skal være på gang.

Christian Jørgensen. Foto: Biotec Pharmacon

Christian Jørgensen. Foto: Biotec Pharmacon

Artikkel av: Odd Steinar Parr
14. juni 2018 - 16.47
An Error Occurred: Forbidden

Oops! An Error Occurred

The server returned a "403 Forbidden".

Something is broken. Please let us know what you were doing when this error occurred. We will fix it as soon as possible. Sorry for any inconvenience caused.

Biotec Pharmacon har hyret inn Carnegie som tilrettelegger for en rettet emisjon på inntil 4,39 millioner nye aksjer, går det frem av en børsmelding.

4,39 millioner aksjer utgjør rundt ti prosent av utstedt aksjekapital i selskapet.

Nettoprovenyet vil bli brukt til å finansiere en rekke spennende muligheter «som kan utvikles til verdiskapende virksomhet».

Blant disse mulighetene trekker selskapet frem SBG og ArcticZymes.

Les mer her.

Biotec Pharmacon falt 0,4 prosent til 5,70 kroner i torsdagens handel på Oslo Børs.

An Error Occurred: Forbidden

Oops! An Error Occurred

The server returned a "403 Forbidden".

Something is broken. Please let us know what you were doing when this error occurred. We will fix it as soon as possible. Sorry for any inconvenience caused.
An Error Occurred: Forbidden

Oops! An Error Occurred

The server returned a "403 Forbidden".

Something is broken. Please let us know what you were doing when this error occurred. We will fix it as soon as possible. Sorry for any inconvenience caused.